Back
Share

Clinical Immunotherapeutics

Clinical Immunotherapeutics is not currently indexed in Scopus. Published by Adis International Ltd.

ISSN 1172-7039Verify ISSN ↗

Publisher: Adis International Ltd

Scopus · Inactive
0
Indexed in
major indexes

Cost to publish: About US$5,190 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free

Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.

Is Clinical Immunotherapeutics indexed in Scopus? No — it was previously covered by Scopus but its coverage is now inactive/discontinued (1994–1996).

What is the impact factor of Clinical Immunotherapeutics? Clinical Immunotherapeutics has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.

Is Clinical Immunotherapeutics in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).

Is Clinical Immunotherapeutics open access? No — it is not registered as an open-access journal in DOAJ or Scopus.

Impact & reach — open metrics via OpenAlex

101
h-index
7.67
2-yr mean citations
1,083
i10-index
1,992
works indexed
53,208
total citations
Papers published per year
0501002017: 48 papers4820172018: 65 papers6520182019: 71 papers7120192020: 62 papers6220202021: 51 papers5120212022: 60 papers6020222023: 66 papers6620232024: 58 papers5820242025: 61 papers6120252026: 52 papers so far522026*

Clinical Immunotherapeutics published 61 papers in 2025; its busiest recent year was 2019 with 71. 2026* is the year so far.

Main topics
Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies ResearchRheumatoid Arthritis Research and TherapiesImmunotherapy and Immune Responses

h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.

Who publishes here — latest 97 articles, 2025–2026

Author countriesUnited StatesUnited States16.5%ChinaChina14.4%South KoreaSouth Korea8.2%NetherlandsNetherlands6.4%SpainSpain5.8%ItalyItaly4.8% Most frequent institutions (papers)Erasmus MCErasmus MC5Erasmus University RotterdamErasmus University Rotterdam4University of LisbonUniversity of Lisbon4Universitat Autònoma de BarcelonaUniversitat Autònoma de Barcelo…3Leiden University Medical CenterLeiden University Medical Center3

In its latest 97 research articles (2025–2026), authors are most often from United States (16.5%), China (14.4%) and South Korea (8.2%). Countries are counted fractionally, so a paper by authors from two countries counts half to each.

Integrity signals — indicators, not proof of misconduct

  • Scopus statusInactive — coverage ended 1996
  • Retracted papers None recorded

Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.

Official sources & links

Scopus source ↗ ISSN Portal · 1172-7039 ↗

Related journals

← Back to Journal Finder

Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.